Identified Gefitinib Metabolism-Related lncRNAs can be Applied to Predict Prognosis, Tumor Microenvironment, and Drug Sensitivity in Non-Small Cell Lung Cancer

Identified Gefitinib Metabolism-Related lncRNAs can be Applied to Predict Prognosis, Tumor Microenvironment, and Drug Sensitivity in Non-Small Cell Lung Cancer

Gefitinib has shown promising efficacy in the treatment of patients with locally advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC). Molecular biomarkers for gefitinib metabolism-related lncRNAs have not yet been elucidated. Here, we downloaded relevant genes and matched them to...

Full description

Bibliographic Details
Main Authors: Weilong Ye, Zhengguo Wu, Pengbo Gao, Jianhao Kang, Yue Xu, Chuzhong Wei, Ming Zhang, Xiao Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
drug sensitivity
gefitinib
lncRNAs
non-small cell lung cancer
P450
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.939021/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.939021/full

Similar Items